A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children ’s Oncology Group Phase 1 and Pilot Consortium Trial (ADVL1315)

Cancer, EarlyView.

Source: Cancer - November 5, 2018 Category: Cancer & Oncology Authors: James I. Geller, Elizabeth Fox, Brian K. Turpin, Stuart L. Goldstein, Xiaowei Liu, Charles G. Minard, Rachel A. Kudgus, Joel M. Reid, Stacey L. Berg, Brenda J. Weigel Source Type: research